A dynamic nomogram and risk classification for predicting prognosis in renal cell carcinoma with venous tumor thrombus
BACKGROUND: To establish an effective dynamic nomogram and a novel risk classification system to predict overall survival (OS) for Renal Cell Carcinoma with venous tumor thrombus (RCC-VTT). METHODS: 318 patients were enrolled and randomly divided into a training set and a validation set in a 7:3 ratio. LASSO regression analysis and multivariate Cox regression analysis were employed to identify significant prognostic factors. Based on these factors, a nomogram model was developed and evaluated using the concordance index (C-index), receiver operating characteristic (ROC) curves, calibration curves, and decision curve analyses (DCA). Survival differences were assessed using Kaplan-Meier curves and the log-rank test. RESULTS: Eight survival predictors were identified: Mayo Clinic Stage, Histology, N Stage, M Stage, Renal Sinus Invasion, Sarcomatoid Feature, Hemoglobin, and Estimated Glomerular Filtration Rate. The C-indexes for the training and validation sets were 0.77 (95% CI: 0.72-0.82) and 0.75 (95% CI: 0.68-0.82), respectively. The AUCs for the training and validation sets were 0.869 (95% CI: 0.805-0.933) and 0.854 (95% CI: 0.770-0.937) for the 5-yr predictions, respectively. DCA further confirmed the clinical utility of the model. Additionally, the nomogram-based classification system stratified patients into distinct risk subgroups for OS (P < 0.0001). CONCLUSIONS: We developed a dynamic nomogram and novel risk classification system for RCC-VTT. This tool has the potential to personalize treatment strategies.
Authors
- S S Zhang
- Liyuan Ge (ORCID: https://orcid.org/0000-0002-5158-0311)
- Shaohui Deng (ORCID: https://orcid.org/0000-0001-9883-8570)
- Haitao Zhang (ORCID: https://orcid.org/0000-0002-1639-4089)
- Zezhen Zhou
- M Lu
- GuoLiang Wang
- Fan Zhang
Institutions
- Peking University (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- BMC Urology
- Published
- 2026-05-18
- DOI
- https://doi.org/10.1186/s12894-026-02158-6
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China